919
Views
45
CrossRef citations to date
0
Altmetric
Original Article

The changing face of Usher syndrome: Clinical implications

El aspecto cambiante del síndrome de Usher: implicaciones clínicas

, &
Pages 82-93 | Received 08 Mar 2006, Published online: 07 Jul 2009

References

  • Adato A., Vreugde S., Joensuu T., Avidan N., Hamalainen R., et al. USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory synapses. Eur J Hum Genet 2002; 10: 339–350
  • Adato A., Michel V., Kikkawa Y., Reiners J., Alagramam K.N., et al. Interactions in the network of Usher syndrome type 1 proteins. Hum Mol Genet 2005; 14(3)347–56
  • Ahmed Z.M., Riazuddin S., Ahmad J., Bernstein S.L., Guo Y., et al. PCDH15 is expressed in the neurosensory epithelium of the eye and ear and mutant alleles are responsible for both USH1F and DFNB23. Hum Mol Genet 2003; 12: 3215–3223
  • Ahmed Z.M., Riazuddin S., Bernstein S.L., Ahmed Z., Khan S., et al. Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F. Am J Hum Genet 2001; 69: 25–34
  • Alagramam K.N., Yuan H., Kuehn M.H., Murcia C.L., Wayne S., et al. Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet 2001; 10: 1709–18
  • Aller E., Jaijo T., Oltra S., Alio J., Galan F., et al. Mutation screening of USH3 gene (clarin-1) in Spanish patients with Usher syndrome: Low prevalence and phenotypic variability. Clin Genet 2004a; 66: 525–29
  • Aller E., Najera C., Millan J.M., Oltra J.S., Perez-Garrigues H., et al. Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments. Eur J Hum Genet 2004b; 12: 407–10
  • Astuto L.M., Bork J.M., Weston M.D., Askew J.W., Fields R.R., et al. CDH23 mutation and phenotype heterogeneity: A profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet 2002a; 71: 262–75
  • Astuto L.M., Kelley P.M., Askew J.W., Weston M.D., Smith R.J., et al. Searching for evidence of DFNB2. Am J Med Genet, 109 2002b; 2002(4)291–97
  • Astuto L.M., Weston M.D., Carney C.A., Hoover D.M., Cremers C.W., et al. Genetic heterogeneity of Usher syndrome: Analysis of 151 families with Usher type 1. Am J Hum Genet 2000; 67: 1569–74
  • Ben Yosef T., Ness S.L., Madeo A.C., Bar-Lev A., Wolfman J.H., et al. A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome. N Engl J Med 2003; 348: 1664–70
  • Bernal S., Meda C., Solans T., Ayuso C., Garcia-Sandoval B., et al. Clinical and genetic studies in Spanish patients with Usher syndrome type 2: Description of new mutations and evidence for a lack of genotype/phenotype correlation. Clin gen 2005; 68(3)204–14
  • Bhattacharya G., Miller C., Kimberling W.J., Jablonski M.M., Cosgrove D. Localization and expression of usherin: A novel basement membrane protein defective in people with Usher's syndrome type 2a. Hear Res 2002; 163: 1–11
  • Blaydon D.C., Mueller R.F., Hutchin T.P., Leroy B.P., Bhattacharya S.S., et al. The contribution of USH1C mutations to syndromic and non-syndromic deafness in the UK. Clin Genet 2003; 63: 303–7
  • Boeda B., El Amraoui A., Bahloul A., Goodyear R., Daviet L., et al. Myosin VIIa, harmonin and cadherin 23, three Usher 1 gene products that cooperate to shape the sensory hair cell bundle. EMBO J 2002; 21: 6689–99
  • Bolz H., von Brederlow B., Ramirez A., Bryda E.C., Kutsche K., et al. Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. Nat Genet 2001; 27: 108–12
  • Bork J.M., Morell R.J., Khan S., Riazuddin S., Wilcox E.R., et al. Clinical presentation of DFNB12 and Usher syndrome type 1D. Adv Otorhinolaryngol 2002; 61: 145–52
  • Bork J.M., Peters L.M., Riazuddin S., Bernstein S.L., Ahmed Z.M., et al. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet 2001; 68: 26–37
  • Boughman J.A., Vernon M., Shaver K.A. Usher syndrome: Definition and estimate of prevalence from two high-risk populations. J Chronic Dis 1983; 36: 595–603
  • Brownstein Z., Ben Yosef T., Dagan O., Frydman M., Abeliovich D., et al. The R245X mutation of PCDH15 in Ashkenazi Jewish children diagnosed with nonsyndromic hearing loss foreshadows retinitis pigmentosa. Pediatr Res 2004; 55: 995–1000
  • Chaib H., Kaplan J., Gerber S., Vincent C., Ayadi H., et al. A newly identified locus for Usher syndrome type 1, USH1E, maps to chromosome 21q21. Hum Mol Genet 1997; 6: 27–31
  • Cohen M., Bellman S., Pembrey M.E., Luxon L.M. Auditory and vestibular findings in autosomal recessive non-syndromal hearing impairment. J Aud Med 1999; 8: 154–173
  • Dreyer B., Tranebjaerg L., Brox V., Rosenberg T., Moller C., et al. A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. Am J Hum Genet 2001; 69: 228–34
  • Dreyer B., Tranebjaerg L., Rosenberg T., Weston M.D., Kimberling W.J., et al. Identification of novel USH2A mutations: Implications for the structure of USH2A protein. Eur J Hum Genet 2000; 8: 500–506
  • Espinos C., Millan J.M., Beneyto M., Najera C. Epidemiology of Usher syndrome in Valencia and Spain. Community Genet 1998; 1: 223–28
  • Eudy J.D., Sumegi J. Molecular genetics of Usher syndrome. Cell Mol Life Sci 1999; 56: 258–67
  • Eudy J.D., Weston M.D., Yao S., Hoover D.M., Rehm H.L., et al. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type 2a. Science 1998; 280: 1753–57
  • Fields R.R., Zhou G., Huang D., Davis J.R., Moller C., et al. Usher syndrome type 3: Revised genomic structure of the USH3 gene and identification of novel mutations. Am J Hum Genet 2002; 71: 607–17
  • Gasparini P., De Fazio A., Croce A.I., Stanziale P., Zelante L. Usher syndrome type 3 (USH3) linked to chromosome 3q in an Italian family. J Med Genet 1998; 35: 666–67
  • Gerber S., Bonneau D., Gilbert B., Munnich A., Dufier J.L., et al. USH1A: Chronicle of a slow death. Am J Hum Gen 2006; 78(2)357–59
  • Grondahl J. Estimation of prognosis and prevalence of retinitis pigmentosa and Usher syndrome in Norway. Clin Genet 1987; 31(4)255–64
  • Grondahl J., Mjoen S. Usher syndrome in four Norwegian counties. Clin Genet 1986; 30: 14–28
  • Hasson T., Heintzelman M.B., Santos-Sacchi J., Corey D.P., Mooseker M.S. Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B. Proc Natl Acad Sci USA 1995; 92: 9815–19
  • Hmani M., Ghorbel A., Boulila-Elgaied A., Ben Zina Z., Kammoun W., et al. A novel locus for Usher syndrome type 2, USH2B, maps to chromosome 3 at p23-24.21. Eur J Hum Genet 1999; 7: 363–67
  • Hmani-Aifa M., Ben Arab S., Kharrat K., Orten D.J., Boulila-Elgaied A., et al. Distinctive audiometric features between USH2A and USH2B subtypes of Usher syndrome. J Med Genet 2002; 39: 281–83
  • Hope C.I., Bundey S., Proops D., Fielder A.R. Usher syndrome in the city of Birmingham: Prevalence and clinical classification. Br J Ophthalmol 1997; 81: 46–53
  • Huang D., Eudy J.D., Uzvolgyi E., Davis J.R., Talmadge C.B., et al. Identification of the mouse and rat orthologs of the gene mutated in Usher syndrome type 2A and the cellular source of USH2A mRNA in retina, a target tissue of the disease. Genomics 2002; 80: 195–203
  • Iannaccone A., Kritchevsky S.B., Ciccarelli M.L., Tedesco S.A., Macaluso C., et al. Kinetics of visual field loss in Usher syndrome type 2. Invest Ophthalmol Vis Sci 2004; 45: 784–92
  • Joensuu T., Hamalainen R., Yuan B., Johnson C., Tegelberg S., et al. Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. Am J Hum Genet 2001; 69: 673–684
  • Johnson K.R., Gagnon L.H., Webb L.S., Peters L.L., Hawes N.L., et al. Mouse models of USH1C and DFNB18: Phenotypic and molecular analyses of two new spontaneous mutations of the Ush1c gene. Hum Mol Genet 2003; 12: 3075–86
  • Kalay E., de Brouwer A.P., Caylan R., Nabuurs S.B., Wollnik B., et al. A novel D458V mutation in the SANS PDZ binding motif causes atypical Usher syndrome. J Mol Med 2005; 83(12)1025–32
  • Kaplan J., Gerber S., Bonneau D., Rozet J.M., Delrieu O., et al. A gene for Usher syndrome type 1 (USH1A) maps to chromosome 14q. Genomics 1992; 14: 979–87
  • Karjalainen S., Terasvirta M., Karja J., Kaariainen H. An unusual otological manifestation of Usher syndrome in four siblings. Clin Genet 1983; 24: 273–79
  • Karjalainen S., Terasvirta M., Karja J., Kaariainen H. Usher syndrome type 3: ENG findings in four affected and six unaffected siblings. J Laryngol Otol 1985; 99: 43–48
  • Kumar A., Fishman G., Torok N. Vestibular and auditory function in Usher syndrome. Ann Otol Rhinol Laryngol 1984; 93: 600–608
  • Larget-Piet D., Gerber S., Bonneau D., Rozet J.M., Marc S., et al. Genetic heterogeneity of Usher syndrome type 1 in French families. Genomics 1994; 21: 138–43
  • Leroy B.P., Aragon-Martin J.A., Weston M.D., Bessant D.A., Willis C., et al. Spectrum of mutations in USUH2A in British patients with Usher syndrome type 2. Exp Eye Res 2001; 72: 503–509
  • Liu X., Udovichenko I.P., Brown S.D., Steel K.P., Williams D.S. Myosin VIIa participates in opsin transport through the photoreceptor cilium. J Neurosci 1999; 19: 6267–74
  • Liu X., Vansant G., Udovichenko I.P., Wolfrum U., Williams D.S. Myosin VIIa, the product of the Usher 1B syndrome gene, is concentrated in the connecting cilia of photoreceptor cells. Cell Motil Cytoskeleton 1997b; 37: 240–52
  • Liu X.Z., Hope C., Walsh J., Newton V., Ke X.M., et al. Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. Am J Hum Genet 1998; 63: 909–12
  • Liu X.Z., Walsh J., Mburu P., Kendrick-Jones J., Cope M.J., et al. Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nat Genet 1997a; 16: 188–90
  • Loundon N., Marlin S., Busquet D., Denoyelle F., Roger G., et al. Usher syndrome and cochlear implantation. Otol Neurotol 2003; 24: 216–21
  • Mansergh F.C., Millington-Ward S., Kennan A., Kiang A.S., Humphries M., et al. Retinitis pigmentosa and progressive sensorineural hearing loss caused by a C12258A mutation in the mitochondrial MTTS2 gene. Am J Hum Genet 1999; 64: 971–85
  • Marietta J., Walters K.S., Burgess R., Ni L., Fukushima K., et al. Usher syndrome type 1C: Clinical studies and fine-mapping the disease locus. Ann Otol Rhinol Laryngol 1997; 106: 123–28
  • Mets M.B., Young N.M., Pass A., Lasky J.B. Early diagnosis of Usher syndrome in children. Trans Am Ophthalmol Soc 2000; 98: 237–42
  • Moller C.G., Kimberling W.J., Davenport S.L., Priluck I., White V., et al. Usher syndrome: An otoneurologic study. Laryngoscope 1989; 99: 73–79
  • Mustapha M., Chouery E., Torchard-Pagnez D., Nouaille S., Khrais A., et al. A novel locus for Usher syndrome type I, USH1G, maps to chromosome 17q24–25. Hum Genet 2002; 110: 348–50
  • Najera C., Beneyto M., Blanca J., Aller E., Fontcuberta A., et al. Mutations in myosin VIIA (MYO7A) and usherin (USH2A) in Spanish patients with Usher syndrome types 1 and 2, respectively. Hum Mutat 2002; 20: 76–77
  • Ness S.L., Ben Yosef T., Bar-Lev A., Madeo A.C., Brewer C.C., et al. Genetic homogeneity and phenotypic variability among Ashkenazi Jews with Usher syndrome type 3. J Med Genet 2003; 40: 767–72
  • Otterstedde C.R., Spandau U., Blankenagel A., Kimberling W.J., Reisser C. A new clinical classification for Usher's syndrome based on a new subtype of Usher syndrome type 1. Laryngoscope 2001; 111: 84–86
  • Ouyang X.M., Hejtmancik J.F., Jacobson S.G., Xia X.J., Li A., et al. USH1C: A rare cause of USH1 in a non-Acadian population and a founder effect of the Acadian allele. Clin Genet 2003; 63: 150–153
  • Ouyang X.M., Yam D., Hejtmancik J.F., Jacobson S.G., Li A.R., et al. Mutational spectrum in Usher syndrome type 2. Clin Genet 2004; 65: 288–93
  • Ouyang X.M., Yan D., Du L.L., Hejtmancik J.F., Jacobson S.G., et al. Characterization of Usher syndrome type 1 gene mutations in an Usher syndrome patient population. Hum Genet 2005; 116(4)292–99
  • Pakarinen L., Karjalainen S., Simola K.O., Laippala P., Kaitalo H. Usher's syndrome type 3 in Finland. Laryngoscope 1995a; 105: 613–17
  • Pakarinen L., Tuppurainen K., Laippala P., Mantyjarvi M., Puhakka H. The ophthalmological course of Usher syndrome type 3. Int Ophthalmol 1995b; 19: 307–11
  • Pennings R.J., Damen G.W., Snik A.F., Hoefsloot L., Cremers C.W., et al. Audiologic performance and benefit of cochlear implantation in Usher syndrome type 1. Laryngoscope 2006; 116(5)717–22
  • Pennings R.J., Fields R.R., Huygen P.L., Deutman A.F., Kimberling W.J., et al. Usher syndrome type 3 can mimic other types of Usher syndrome. Ann Otol Rhinol Laryngol 2003b; 112: 525–30
  • Pennings R.J., Huygen P.L., Cremers W.R. Hearing impairment in Usher syndrome type 2. Ann Otol Rhinol Laryngol 2003a; 112: 825
  • Pennings R.J., Huygen P.L., Orten D.J., Wagenaar M., Van Aarem A., et al. Evaluation of visual impairment in Usher syndrome 1b and Usher syndrome 2a. Acta Ophthalmol Scand 2004; 82: 131–39
  • Pennings R.J., Huygen P.L., Weston M.D., Van Aarem A., Wagenaar M., et al. Pure tone hearing thresholds and speech recognition scores in Dutch patients carrying mutations in the USH2A gene. Otol Neurotol 2003c; 24: 58–63
  • Plantinga R.F., Kleemola L., Huygen P.L., Joensuu T., Sankila E.M., et al. Serial audiometry and speech recognition findings in Finnish Usher syndrome type 3 patients. Audiol Neurootol 2005; 10: 79–89
  • Plantinga R.F., Pennings R.J., Huygen P.L., Sankila E.M., Tuppurainen K., et al. Visual impairment in Finnish Usher syndrome type 3. Acta Ophthalmol Scand 2006; 84: 36–41
  • Reiners J., van Wijk E., Marker T., Zimmermann U., Jurgens K., et al. Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome. Hum Mol Gen 2005; 14: 3933–43
  • Reisser C.F., Kimberling W.J., Otterstedde C.R. Hearing loss in Usher syndrome type 2 is non-progressive. Ann Otol Rhinol Laryngol 2002; 111: 1108–11
  • Rivolta C., Sweklo E.A., Berson E.L., Dryja T.P. Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss. Am J Hum Genet 2000; 66: 1975–78
  • Sadeghi M., Cohn E.S., Kelly W.J., Kimberling W.J., Tranebjoerg L., et al. Audiological findings in Usher syndrome types 2a and 2 (non-2a). Int J Audiol 2004; 43: 136–43
  • Sadeghi M., Cohn E.S., Kimberling W.J., Tranebjoerg L., Moller C. Audiological and vestibular features in affected subjects with USH3: A genotype/phenotype correlation. Int J Audiol 2005; 44: 307–16
  • Sadeghi A.M., Eriksson K., Kimberling W.J., Sjöström A., Möller C. Long-term visual prognosis in Usher syndrome type 1 and 2. Acta Ophthal Scand 2006; 83: 1–8
  • Sankila E.M., Pakarinen L., Kaariainen H., Aittomaki K., Karjalainen S., et al. Assignment of an Usher syndrome type 3 (USH3) gene to chromosome 3q. Hum Mol Genet 1995; 4: 93–8
  • Seeliger M., Pfister M., Gendo K., Paasch S., Apfelstedt-Sylla E., et al. Comparative study of visual, auditory, and olfactory function in Usher syndrome. Graefes Arch Clin Exp Ophthalmol 1999; 237: 301–7
  • Seeliger M.W., Zrenner E., Apfelstedt-Sylla E., Jaissle G.B. Identification of Usher syndrome subtypes by ERG implicit time. Invest Ophthalmol Vis Sci 2001; 42: 3066–71
  • Seyedahmadi B.J., Rivolta C., Keene J.A., Berson E.L., Dryja T.P. Comprehensive screening of the USH2A gene in Usher syndrome type 2 and non-syndromic recessive retinitis pigmentosa. Exp Eye Res 2004; 79: 167–73
  • Siemens J., Lillo C., Dumont R.A., Reynolds A., Williams D.S., et al. Cadherin 23 is a component of the tip link in hair-cell stereocilia. Nature 2004; 428: 950–55
  • Smith R.J., Berlin C.I., Hejtmancik J.F., Keats B.J., Kimberling W.J., et al. Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium. Am J Med Genet 1994; 50: 32–38
  • Smith R.J., Pelias M.Z., Daiger S.P., Keats B., Kimberling W., et al. Clinical variability and genetic heterogeneity within the Acadian Usher population. Am J Med Genet 1992; 43: 964–969
  • Spandau U.H., Rohrschneider K. Prevalence and geographical distribution of Usher syndrome in Germany. Graefes Arch Clin Exp Ophthalmol 2002; 240: 495–98
  • Tamagawa Y., Ishikawa K., Ishikawa K., Ishida T., Kitamura K., et al. Phenotype of DFNA11: a nonsyndromic hearing loss caused by a myosin VIIA mutation. Laryngoscope 2002; 112: 292–97
  • Tsilou E.T., Rubin B.I., Caruso R.C., Reed G.F., Pikus A., et al. Usher syndrome clinical types 1 and 2: Could ocular symptoms and signs differentiate between the two types?. Acta Ophthalmol Scand 2002; 80: 196–201
  • Van Aarem A., Wagenaar M., Pinckers A.J., Huygen P.L., Bleeker-Wagemakers E.M., et al. Ophthalmologic findings in Usher syndrome type 2A. Ophthalmic Genet 1995; 16: 151–8
  • Van Aarem A., Pinckers A.J., Kimberling W.J., Huygen P.L., Bleeker-Wagemakers E.M., et al. Stable and progressive hearing loss in type 2A Usher syndrome. Ann Otol Rhinol Laryngol 1996; 105: 962–67
  • Van Wijk E., Pennings R.J., Te B.H., Claassen A., Yntema H.G., et al. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type 2. Am J Hum Genet 2004; 74: 738–44
  • Wagenaar M., Van Aarem A., Huygen P., Pieke-Dahl S., Kimberling W., et al. Hearing impairment related to age in Usher syndrome types 1B and 2A. Arch Otolaryngol Head Neck Surg 1999; 125: 441–45
  • Weil D., Blanchard S., Kaplan J., Guilford P., Gibson F., et al. Defective myosin VIIA gene responsible for Usher syndrome type 2B. Nature 1995; 374: 60–61
  • Weil D., El Amraoui A., Masmoudi S., Mustapha M., Kikkawa Y., et al. Usher syndrome type 1G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin. Hum Mol Genet 2003; 12: 463–71
  • Weil D., Kussel P., Blanchard S., Levy G., Levi-Acobas F., et al. The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nat Genet 1997; 16: 191–3
  • Weston M.D., Eudy J.D., Fujita S., Yao S., Usami S., et al. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type 2. Am J Hum Genet 2000; 66: 1199–1210
  • Weston M.D., Kelley P.M., Overbeck L.D., Wagenaar M., Orten D.J., et al. Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients. Am J Hum Genet 1996; 59: 1074–1083
  • Weston M.D., Luijendijk M.W., Humphrey K.D., Moller C., Kimberling W.J. Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type 2. Am J Hum Genet 2004; 74: 357–66
  • Young N.M., Mets M.B., Hain T.C. Early diagnosis of Usher syndrome in infants and children. Am J Otol 1996; 17: 30–34
  • Zina Z.B., Masmoudi S., Ayadi H., Chaker F., Ghorbel A.M., et al. From DFNB2 to Usher syndrome: Variable expressivity of the same disease. Am J Med Genet 2001; 101: 181–83

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.